Correspondence in response to OSIN-D-18-00831 quantifying imminent risk

Affiliations

• ¹ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@sheffield.ac.uk.
• ² Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia. w.j.pontefract@sheffield.ac.uk.
• ³ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
• ⁴ Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
• ⁵ MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
• ⁶ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
• ⁷ Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
• ⁸ Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
• ⁹ LIME/MMC, Karolinska Institutet, Stockholm, Sweden.
• ¹⁰ Mellanby Centre for Bone Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.